These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32686466)

  • 1. Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.
    McLaughlin K; Carabetta S; Hunt N; Schuler BR; Ting C; Tran LK; Szumita PM; Anger KE
    Ann Pharmacother; 2021 Feb; 55(2):181-186. PubMed ID: 32686466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis.
    Alkazemi A; McLaughlin KC; Chan MG; Schontz MJ; Anger KE; Szumita PM
    Drug Saf; 2022 Jan; 45(1):19-26. PubMed ID: 34716562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center.
    Wang FY; McLaughlin KC; Schontz MJ; DeGrado JR; Dannemiller RE
    Clin Drug Investig; 2024 Mar; 44(3):175-181. PubMed ID: 38363545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center.
    Corrado MJ; Riselli A; McLaughlin KC; Szumita PM; Anger KE
    J Pharm Pract; 2023 Apr; 36(2):281-285. PubMed ID: 34384303
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
    Shim A; Radparvar S; Davis N; Kaplan A; Kantaris K; Devlin A; Liang J; Ciummo F
    J Pharm Pract; 2024 Jun; 37(3):722-727. PubMed ID: 37231709
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and Efficiency of Intravenous Push Lacosamide Administration.
    Davidson KE; Newell J; Alsherbini K; Krushinski J; Jones GM
    Neurocrit Care; 2018 Dec; 29(3):491-495. PubMed ID: 29949010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit.
    Adams T; Greathouse K
    Neurocrit Care; 2021 Dec; 35(3):789-793. PubMed ID: 34081297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Tolerability of Intravenous Push Lacosamide and Levetiracetam.
    Ragoonanan D; Tran N; Levesque M
    J Pharm Pract; 2023 Oct; 36(5):1056-1060. PubMed ID: 35348010
    [No Abstract]   [Full Text] [Related]  

  • 9. High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration.
    Gill CM; Kenney RM; Makowski CT; Davis SL
    Hosp Pharm; 2021 Aug; 56(4):328-331. PubMed ID: 34381269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center.
    Hunt NF; McLaughlin KC; Kovacevic MP; Lupi KE; Dube KM
    Ann Pharmacother; 2021 Sep; 55(9):1127-1133. PubMed ID: 33455436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Profile of High-Dose Intravenous Push Lacosamide.
    Torian SC; Jones GM
    Neurohospitalist; 2023 Jul; 13(3):278-282. PubMed ID: 37441206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of First-Dose, Intravenous Push Penicillins and Carbapenems in the Emergency Department.
    Academia EC; Jenrette JE; Mueller SW; McLaughlin JM
    J Pharm Pract; 2022 Jun; 35(3):369-376. PubMed ID: 33302785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of intravenous push administration of beta-lactams within a healthcare system.
    Marsh K; Ahmed N; Decano A; Dubrovskaya Y; Jen SP; Siegfried J; Chen XJC; Merchan C
    Am J Health Syst Pharm; 2020 Apr; 77(9):701-708. PubMed ID: 34278415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of postinfusion phlebitis in intravenous push versus intravenous piggyback cefazolin.
    Biggar C; Nichols C
    J Infus Nurs; 2012; 35(6):384-8. PubMed ID: 23132087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intravenous Push and Piggyback Administration of Ceftriaxone on Mortality in Sepsis.
    Lim SY; Baek S; Jo YH; Lee JH; Um YW; Kim HE; Han D
    J Emerg Med; 2024 May; 66(5):e632-e641. PubMed ID: 38704306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime Intravenous Push Versus Intravenous Piggyback on Time to Administration of First-Dose Vancomycin in the Emergency Department.
    Tran A; O'Sullivan D; Krawczynski M
    J Pharm Pract; 2018 Dec; 31(6):605-609. PubMed ID: 29046121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous push versus intravenous piggyback beta-lactams for the empiric management of gram-negative bacteremia.
    Marsh K; Dubrovskaya Y; Jen SP; Ahmed N; Decano A; Siegfried J; Papadopoulos J; Merchan C
    J Clin Pharm Ther; 2021 Apr; 46(2):373-381. PubMed ID: 33068313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Intravenous Push Piperacillin-Tazobactam on Time to Antibiotic Administration in Emergency Department Patients with Sepsis.
    Alrashed MA; Kang N; Perona SJ; Torabi MR; Borgstrom MC
    J Pharm Pract; 2023 Aug; 36(4):756-760. PubMed ID: 35220826
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients.
    Smith SE; Halbig Z; Fox NR; Bland CM; Branan TN
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.